Cogent Biosciences, Inc. (COGT) Stock Overview
Explore Cogent Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cogent Biosciences, Inc. (COGT)
Key Financials
Key Financials
Market Cap
6B
P/E Ratio
-15.93
EPS (TTM)
$-2.11
ROE
-0.73%
COGT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Cogent Biosciences, Inc. (NASDAQ: COGT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cogent Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of COGT on the NASDAQ shows an RSI of 42.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $45.27 for the NASDAQ listing.
Key metrics behind Cogent Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -15.93 and a market capitalization of 6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of COGT on the NASDAQ.